Country Profile

Zambia

Zambia is a significant market for Indian pharmaceutical exports — $80.8M in FY 2025–26. Medicines accounts for 82% of shipments, with vaccines contributing $8.94M.

🇿🇲 $80.8M · 0.9× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$80.8M
Exports FY2025–26 DGCIS
0.9×
Growth FY2015→2026
82%
Medicines Share
5
Product Categories Supplied
12
Years of Trade Data
Zambia is a significant market for Indian pharmaceutical exports — $80.8M in FY 2025–26. Medicines accounts for 82% of shipments, with vaccines contributing $8.94M.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $66.1M (81.8%) Vaccines $8.94M (11.1%) Medicine Ingredients $3.31M (4.1%) Surgical & Hospital Supplies $1.66M (2.1%) Traditional & Herbal $776K (1.0%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Zambia in the RBI overseas direct investment dataset (2011–2026).